HDL-C reductions in both the single and multiple ascending dose studies resembled those of homozygous familial hypercholesterolemia patients treated with evinacumab.36 Lowered HDL-C probably stems from enhanced endothelial lipase activity. This evidence concerns the gene LIPG and familial hypercholesterolemia.